![](/img/cover-not-exists.png)
Loss of RALT/MIG-6 expression in ERBB2-amplified breast carcinomas enhances ErbB-2 oncogenic potency and favors resistance to Herceptin
Anastasi, Sergio, Sala, Gianluca, Huiping, Chen, Caprini, Elisabetta, Russo, Giandomenico, Iacovelli, Stefano, Lucini, Fabiana, Ingvarsson, Sigurdur, Segatto, OresteVolume:
24
Year:
2005
Language:
english
Pages:
9
DOI:
10.1038/sj.onc.1208658
File:
PDF, 399 KB
english, 2005